VANGUARD GROUP INC - SEELOS THERAPEUTICS INC ownership

SEELOS THERAPEUTICS INC's ticker is SEEL and the CUSIP is 81577F109. A total of 85 filers reported holding SEELOS THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.12 and the average weighting 0.0%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of SEELOS THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$951,782
-84.1%
5,172,726
+3.5%
0.00%
Q2 2023$5,972,189
+72.2%
4,997,648
-0.4%
0.00%
Q1 2023$3,467,571
+1.8%
5,016,7410.0%0.00%
Q4 2022$3,406,367
-34.0%
5,016,741
+0.0%
0.00%
Q3 2022$5,164,000
+54.1%
5,014,340
+1.8%
0.00%
Q2 2022$3,352,000
-29.2%
4,927,350
-12.8%
0.00%
Q1 2022$4,735,000
-43.6%
5,650,988
+9.8%
0.00%
Q4 2021$8,389,000
-32.8%
5,146,483
-0.6%
0.00%
Q3 2021$12,478,000
-1.5%
5,177,503
+7.9%
0.00%
Q2 2021$12,673,000
-13.1%
4,800,323
+64.3%
0.00%
Q1 2021$14,577,000
+229.6%
2,921,164
+4.3%
0.00%
Q4 2020$4,423,000
+859.4%
2,799,854
+469.7%
0.00%
Q3 2020$461,000
+51.1%
491,487
+63.0%
0.00%
Q2 2020$305,000
+93.0%
301,588
-6.1%
0.00%
Q1 2020$158,000
-50.8%
321,185
+34.3%
0.00%
Q4 2019$321,000
+45.9%
239,2220.0%0.00%
Q3 2019$220,000
-58.0%
239,2220.0%0.00%
Q2 2019$524,000
+33.0%
239,222
+104.2%
0.00%
Q1 2019$394,000117,1360.00%
Other shareholders
SEELOS THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
GENDELL JEFFREY L 4,933,024$4,133,0000.30%
ACUTA CAPITAL PARTNERS, LLC 295,896$248,0000.12%
Connacht Asset Management LP 231,551$194,0000.10%
Uniplan Investment Counsel, Inc. 1,564,605$1,310,0000.08%
AdvisorShares Investments LLC 358,796$301,0000.05%
1492 Capital Management LLC 99,819$84,0000.04%
Woodline Partners LP 2,803,230$2,349,0000.04%
Ikarian Capital, LLC 257,883$215,0000.03%
Sovereign Financial Group, Inc. 75,000$63,0000.02%
Aquatic Capital Management LLC 6,400$5,0000.01%
View complete list of SEELOS THERAPEUTICS INC shareholders